Pfizer CEO Albert Bourla unpacks the impact of the nomination on 'The Claman Countdown.' ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback